The purpose of the present review is to outline the current understanding on the molecular mechanisms governing various stages of oocyte maturation, transition from maternal to embryonic control and the initial steps of pre-embryo development. The cytoplasmic and nuclear maturation of the oocyte during pre-ovulatory development can be viewed as separate entities. Cytoplasmic maturation and the acquisition of stores of RNA and protein dominates oocyte development between the premordial and pre-ovulatory stages of development. Initiation of nuclear maturation is marked by the breakdown of the nuclear envelope, or germinal vesicle and is triggered by the midcycle luteinizing hormone peak. In vitro, this is associated with a decrease in the intracellular concentrations of cAMP. This and several subsequent steps of meiosis are controlled by the M-phase promoting factor (MPF). While the constituents of MPF, p34 cdc2 kinase and B-type cyclin, are also present in mitotically dividing cells, in meiotically dividing oocytes the regulation of MPF activity differs. An oocyte-specific protein kinase, c-mos, plays an important role in upregulating the activity of MPF at various stages of final oocyte maturation. Several lines of evidence suggest that the proper function of the c-mos-MPF system is associated with important features of the last stages of oocyte maturation such as the resumption of meiotic maturation, inhibition of DNA replication between meiosis I and II, and the maintenance of the oocyte at metaphase II arrest until it is fertilized. Eventually the destruction of c-mos and active MPF following fertilization allows the initiation of mitotic cell division in the pre-embryo. The very first cell divisions of the human pre-embryo are still under the control of maternally inherited mRNA and protein. Several lines of evidence suggest that in humans, zygotic gene expression is initiated between the 4-and 8-cell stages, after which the pre-embryo begins to utilize its own genes. Some of the first genes to be expressed in the human pre-embryo encode proteins that are associated with cell division, extracellular growth modulatory signals as well as factors associated with implantation. We acknowledge that most of the data presented comes from species other than human, therefore at present the full biological role of the proposed regulatory pathways and control mechanisms for human biology remains speculative.
Introduction
The understanding of the molecular mechanisms governing the development of the oocyte and early embryo has increased dramatically during recent years. Excellent reviews on the paracrine and endocrine control of follicular development have recently been published (Gougeon, 1996) . The aim of the present review is to create a picture of the molecular mechanisms controlling the fortunate subpopulation of primary oocytes destined to mature, ovulate and complete their meiotic division. In addition, the initial steps of preembryo development are covered. Due to a paucity of studies in human oocytes and pre-embryos, much of the data presented comes from studies of lower organisms. However, the development of novel sensitive tools has allowed studies on human oocytes and pre-embryos. There-fore, special attention is given to human data to complement the emerging picture.
It appears that despite species-specific differences, the basic molecular machinery governing these developmental stages shares many common features in different species. Also, examples of several different regulatory pathways, such as alterations in the intracellular cyclic AMP (cAMP), Ca 2ϩ and protein phosphorylation levels, are evident even during this brief period of development.
Much of the data obtained using human material is descriptive in nature. Even though presence does not necessarily imply function or role, in the present review we have concentrated on regulatory pathways, the elements of which have been shown to be present in human oocytes and pre-embryos, but the roles of which have been characterized in detail in other species.
Oogenesis Cytoplasmic maturation initiates the maturation process
Very little is known about the gonadotrophin independent, initial steps of awakening of the oocyte in the primordial follicle. The first morphological features of follicular growthtransition of the surrounding coronal cells from flattened to cuboidal and increase in the oocyte diameter-mark the initiation of the preantral period of development (Erickson, 1986) . Potential candidates, which might have a role in triggering these first developmental steps have been proposed: expression of retinoblastoma protein, controller of initial cell differentiation, peaks in the preantral human oocytes entering the growth phase (Bukovsky et al., 1995) . C-kit, a tyrosine kinase receptor, is expressed in oocytes, and its ligand, stem cell factor, in the granulosa cells both in the mouse as in the human (Morto and Bernstein, 1993; Tanikawa et al., 1998) . Oocytes in the mice lacking the c-kit-stem cell factor pathway fail to develop beyond the premordial stage (Kuroda et al., 1988) .
At the preantral stage components of zona pellucida, the ZP proteins 1, 2 and 3 are laid down (Rankin and Dean, 1996) . The oocyte-specific expression of ZP3 mRNA has been attributed to conserved regulatory elements in the promoter regions of ZP genes (Liang and Dean, 1993) . Putative, oocyte-specific transcription factors, OSP-1 (oocyte-specific protein-1) and ZAP-1 (zona pellucida gene activating protein-1) binding to the promoter regions of ZP3 gene have been characterized in mouse oocytes (Schickler et al., 1992; Millar et al., 1993) . However, no data are available on the regulation of ZP3 expression in developing human oocytes.
The cytoplasmic maturation occurring between transition from primary to pre-ovulatory oocyte is remarkable. The oocyte diameter increases from~15 to 100 µm, corresponding to a 300-fold increase in volume (Erickson, 1986) . The oocyte is both transcriptionally and translationally very active. A mature mouse oocyte contains~200-and 50-60-fold more RNA and protein, respectively, than an average somatic cell (Wassarman and Kinloch, 1992) . In addition, the content of messenger RNA in the oocyte is high,~15-20%, in contrast to that of~2-3% of a somatic cell. In mouse oocytes several specific mRNA species are highly abundant: mRNA for lactate dehydrogenase, c-kit, ZP3 and c-mos (to be described below) each constitute up to 0.3% of the total pool of mRNA (Roller et al., 1989; Wassarman and Kinloch, 1992) . At the time of resumption of meiosis, the active transcription ceases; however, translation of the mRNA pool continues throughout the final stages of meiosis (Wassarman, 1996) .
Fate of oocyte RNA
The RNA transcribed during the period of cytoplasmic maturation is very stable, with an average t 1 2 of~28 days (Wassarman, 1996) . The fate of different mRNA species are controlled at several levels. Different species of mRNA are polyadenylated to different degrees, the mRNA transcripts with long poly-A tails of~150 A residues are for immediate use, whereas the mRNA with shorter poly-A tails of Ͻ90 A constitute a storage 746 form of RNA to be used only following elongation of the poly-A tail (Bachvarova, 1992) . In mouse oocytes representatives of the former group are mRNA coding for actin and globin proteins, whereas tissue plasminogen activator (tPA) and hypoxanthine phosphoribosyltransferase belong to the latter group (Bachvarova, 1992; Paynton and Bachvarova, 1994) . The mRNA molecules to be polyadenylated harbour specific nucleotide sequences (cytoplasmic polyadenylation element, CPE; and polyadenylation signal, AAUAAA sequence), and are to be used for protein synthesis only following cytoplasmic adenylation by poly (A) polymerase enzyme system (Fox et al., 1992) . CPE-dependent polyadenylation of the mRNA of the cell cycle regulators c-mos, cdk2 and cyclin-B is a prerequisite of oocyte maturation in Xenopus (Stebbins-Boaz et al., 1996) . In addition to regulation of the poly-A tail, different mRNA species differ in their rate of decay, also regulating their availability (Decker and Parker, 1994) .
Gap junctions
The interplay between the surrounding coronal cells and the primary oocyte is of vital importance in the maturation process of the oocyte. The two cell types are interconnected via gap junctions, composed of connexin proteins, which allow transfer of metabolites and regulatory substances between the two cell types. In human follicles the cytoplasmic connections between the oocyte and most proximal granulosa cells can be visualized once the follicle enters a growth phase and the zona pellucida begins to appear (Baca and Zamboni, 1967) . A recent demonstration of failure of oocyte maturation in connexin-37 knockout mice emphasizes the importance of this interconnection for proper oocyte maturation (Simon et al., 1997) . Besides the failure of oocyte maturation in the connexin-37 knock-out mice, an abnormal corpus luteum formation, without ovulation was evident (Simon et al., 1997) . Recent studies by Eppig et al. (1997) have shown that oocyte-derived factors regulate the luteinizing hormone (LH) receptor expression in the cumulus cells in the mouse. Similarly, chemical uncoupling of the oocyte and the coronal cells reversed the inhibitory effects of glucose as well as maturational stimulus of follicle stimulating hormone (FSH) on the oocyte growth in murine oocyte cumulus complexes (Downs, 1995) . Thus these data suggest that the oocyte, in part, controls coronal cell function.
Proposed intrafollicular triggers of oocyte nuclear maturation
Follicular fluid collected from growing follicles contains steroids and growth factors such as increasing concentrations of oestradiol and insulin-like growth factor-I (IGF-I) (Artini et al., 1994) . Human oocytes have been shown to contain mRNA for the oestrogen receptor, IGF-I, IFG-II and IGF-I receptor (Wu et al., 1993; Zhou and Bondy, 1993; Lighten et al., 1997) . In addition, following the preantral stage of development, human oocytes express both epidermal growth factor (EGF) and EGF receptor (Maruo et al., 1993; Bennett et al., 1996) ; follicular fluid also contains EFG (Artini et al., 1994) . Nuclear maturation of immature human oocytes was enhanced when oocyte-cumulus complexes were cultured in the presence of EGF or IFG-I (Gómez et al., 1993a) . Whether these factors promote the nuclear maturation via their direct effects on the oocyte, or via the coronal cells, also expressing EGF, EGF receptors and IGF receptors (Maruo et al., 1993) is not known. However, fertilization or resulting embryo quality was not enhanced when human oocytes were fertilized in the presence of EGF (Gómez et al., 1993b) .
Activin and inhibin produced by the granulosa cells, acting both on the oocyte and the granulosa cells, are emerging as an important intrafolliclar growth factors. These paracrine factors may act on the oocyte either directly or via gap junctions: mRNA transcripts for activin receptor subtypes I and II are present in human oocytes (Sidis et al., 1997) . Activin and inhibin promote the in-vitro maturation and fertilization of primate oocytes (Alak et al., 1996) . In a culture system of immature mouse granulosa cells and oocytes, the addition of FSH and activin induced follicle-like structures, capable of responding appropriately to LH (Li et al., 1995) . Moreover, disruption of the gap juction-mediated communication between the oocyte and granulosa cells abolished the follicle organizing activity of activin (Li and Mather, 1997) . These data further underline the role of the oocyte in the process of follicular development.
Declining cAMP triggers nuclear maturation
Several lines of evidence suggest that cAMP, produced by the granulosa cells and transported via gap junctions into the oocyte, has an important role in maintaining the meiotic arrest of the oocyte despite the rapid cytoplasmic maturation occurring prior to ovulation. In vitro, meiotic division is resumed when the intracellular concentrations of cAMP decline, an effect mediated via the surrounding coronal cells (Downs, 1995) . Also human oocytes, when prematurely removed from their follicular environment, rapidly resume the meiotic division (Edwards, 1965) . Maintaining the elevated concentrations of cAMP in the oocyte, either by inhibition of phosphodiesterase or by incorporation of cyclic nucleotides into culture media, inhibits the resumption of meiosis (Törnell and Hillensjö, 1993) . Thus it has been proposed that disruption of the gapjunction-mediated communication at the time of mid-cycle gonadotrophin surge results in the continuation of the meiotic division, most likely mediated via declining intracellular concentrations of cAMP (Racowsky et al., 1989) . Figure 1 depicts the cytosolic and nuclear maturation in relation to mid-cycle LH surge, and the proposed molecular mechanisms triggering continuation of meiosis.
It may be speculated that the cAMP-dependent kinases maintain the nuclear prophase I arrest via phosporylation of the regulatory proteins responsible for initiation of nuclear maturation. The inactive form of M-phase promoting factor (MPF) is phosporylated. In fact, in Xenopus oocytes, high concentrations of cAMP-dependent protein kinase A have been shown to result in phosphorylation of the p34cdc2 subunit of MPF, and thus inhibit activation of MPF (Rime et al., 1992) .
Molecules of meiosis M-phase promoting factor controls the meiotic completion
Resumption of meiotic division from the prophase of the first meiotic division (PI), where the primary oocyte has been 747 arrested since early fetal development, is surely a feature unlike any other in biology. The molecular mechanisms controlling meiosis, and the regulation of the cell cycle in general, began to be understood in 1971 with the characterization of Mphase promoting factor (MPF, also referred to as maturation promoting factor) in mature Xenopus oocytes (Masui and Markert, 1971; Smith and Ecker 1971) . MPF was originally characterized as an activity present in mature frog oocytes, which could rapidly induce nuclear maturation when injected even in minute quantities into immature oocytes. The biological test of MPF activity is illustrated in Figure 2 .
Cyclins were first characterized in marine invertebrate embryos. The concentrations of cyclin protein fluctuated in a cyclical pattern according to the phase of the cell division cycle (Evans et al., 1983) . Eventual characterization of MPF revealed that the active MPF is indeed composed of a regulatory cyclin B-subunit and a catalytic p34 cdc2 serine/threonine kinase (Dunphy et al., 1988; Gautier et al., 1988 Gautier et al., ,1990 Pines and Hunter, 1989) . In addition to opening a new era in understanding oocyte biology, MPF was the first of the cyclin-cyclindependent kinase (cdk) complexes to be characterized. The cyclin-cdk dimers, their regulation and regulatory controls have emerged as central mediators of the cell cycle at its various stages, and are a subject of intense research.
In accordance with the cyclical expression of the cyclins, periodic activity is a characteristic feature of MPF. In somatic cells, newly assembled MPF is needed for each cell division, whereas the degradation of MPF at the end of mitosis is required for cells to complete mitosis (Minshull et al., 1989; Glotzer et al., 1991) . Indeed, the build-up of cyclin-B before, and its degradation at the end, of cell division explains the periodicity of MPF activity (Pines and Hunter 1989) . Moreover, cyclin-B seems to be the sole mRNA species required at the G2-M transition; addition of cyclin-B mRNA was sufficient to induce cell division in cell-free extracts of Xenopus oocytes devoid of endogenous mRNA (Murray and Kirshner 1989) . Thus cyclin-B mRNA synthesis appears to control meiotic division as well. In accordance, human oocytes contain cyclin-B1 mRNA (Heikinheimo et al., 1995b) , the dominant cyclin-B isoform in mouse oocytes (Chapman and Wolgemuth, 1992) . Figure 3 shows the assembly and activation pathway of MPF.
In comparison with mitotically dividing somatic cells, the behaviour of MPF in meiotically dividing oocytes is different. Oocyte maturation is characterized by two peaks of high MPF activity: the first occurring at the time of resumption of the meiotic division, and the second, a sustained one, during the meiotic arrest at the MII stage (Mattioli et al., 1991 , Furuno et al., 1994 . During the interval between these two peaks, MPF activity is maintained at a fairly high level. As described below, this sustained MPF activity between meiosis I and II is likely to be of pivotal importance in inhibiting DNA replication, thus making the reductive cell division possible. Figure 4 depicts a summary of the MPF activity at different stages of murine and bovine oocyte maturation in vitro (Fulka et al., 1992; Wu et al., 1997) .
In contrast to immature Xenopus oocytes, which contain high concentrations of inactive 'pre-MPF' to be rapidly activated (Gautier and Maller, 1991; Christmann et al., 1994) , the . Despite the 300-fold increase in the volume of the oocyte, the nucleus is maintained at prophase of the first meiotic division (PI) until the midcycle luteinizing hormone (LH) surge. The ovulatory LH peak triggers the nuclear maturation, and thus awakens the dormant nucleus. The first meiotic division is completed by the time of ovulation, after which the nuclear development again arrests at the metaphase of the second meiotic division (MII) until fertilized. The proposed molecular mechanism of continuation of meiosis is outlined: LH surge triggers disruption of the gap junctions (GJ) between the oocyte and the coronal cells. This results in a decline of the intra-oocyte concentrations of cAMP, triggering continuation of meiosis via activation of maturation promoting factor (MPF). In addition c-mos protein kinase is likely to have a role in activation of MPF. components of MPF, namely p34 cdc2 kinase and cyclin-B, are synthesized during the first hours of in-vitro maturation in bovine oocytes (Wu et al., 1997) . In marmoset monkey oocytes, the competence to resume meiotic division was strictly related to follicular stage (Gilchrist et al., 1995) . Similarly in the human, the capacity of the oocytes to resume nuclear maturation in vitro increased according to the diameter of the antral follicle (Tsuji et al., 1985) . However, the accumulation kinetics of the components of MPF, and its regulators, during maturation of human oocytes is not currently known. When analysed for the content of cyclin-B1 and c-mos mRNA, no difference was noted between immature nuclear PI and mature MII oocytes collected following ovarian stimulation (Heikinheimo et al., 1996) .
748

Targets of MPF activity
Even though the importance of MPF in oocytes is supported by a wealth of data, surprisingly little is known about its specific molecular targets. However, MPF is thought to be involved in several central features of cell division, such as disassembly of the nucleus, chromosome condensation, cytoskeletal rearrangements and arrest in transcriptional activity (Moreno and Nurse, 1990) . Histone H1 is a classical substrate of MPF activity, thus MPF is often also referred to as histone kinase (Langan et al., 1989) . Histone H1 has an important role in packaging DNA into nucleosomes, the primary structural units of chromatin fibres. Phosphorylation of histone H1 is believed to have a role in chromosome condensation during cell division (Bradbury et al., 1974) . Fulka et al. (1992) and Wu et al. (1997) on data on the maturation of murine and bovine, respectively, oocytes in vitro.
Nuclear laminins have also been shown to be phosphorylated by the p34cdc2 kinase (Peter et al., 1990) . Phosphorylation of pp60c-src kinase may be responsible for the cytoskeletal rearrangements of cell division (Shenoy et al., 1989) . Similarly, RNA polymerase II has been proposed to be inhibited by MPF (Cisek and Gorden, 1989) ; this would explain the inhibition of transcription at the final stages of oocyte maturation as well as at the time of cell division.
Activation of MPF
Following assembly of the cyclin-B-p34 cdc2 kinase complex, the MFP generated is maintained at an inactive stage via phosphorylation of specific amino acid residues of the p34 cdc2 kinase (Figure 3) (Gu et al., 1992) . The two important inhibitory phosphorylations are brought about by the action of specific protein kinases, namely Wee1 and Mik kinases (Lundgren et al., 1991; McGowan and Russell, 1993) .
Role of cdc25-phosphatase
The cdc25-phosphatase controls the coordinated dephosphorylation and activation of MPF, in several model systems including human cells Millar and Russell, 1992) . Besides acting on the MPF, cdc25 phosphatase itself is also a target of MPF, which via phosphorylation enhances the activity of cdc25 phosphatase (Galaktionov and Beach, 1991; Hoffmann et al., 1993) . Thus a catalytic loop is formed, which may be a prerequisite for the rapid activation of MPF at the initiation of oocyte maturation. This would also explain the very first results on the characterization of MPF (Figure 2) , i.e. injection of 10-20 nl of cytoplasm from mature oocytes into immature oocytes with volumes of~2 µl (dilution factor of 1/100 to 1/200) rapidly activated the MPF of the recipient oocyte (Masui and Markert, 1971) . Figure 5 summarizes the pathways resulting in activation of MPF in oocytes.
Several isozymes of cdc25 phosphatase have been described in the human as well as in the mouse (Millar and Russell, 1992) . In the mouse, the cdc25a isozyme mRNA is present in the oocytes, whereas the cdc25b mRNA is the prominent isoform in mouse pre-embryos (Wickramasinghe et al., 1995) . However, the dominant cdc25 forms in human oocytes and pre-embryos remain to be characterized.
C-mos kinase regulates the MPF activity
A protein kinase likely to up-regulate MPF activity in oocytes starting from reinitiation of meiosis until fertilization is the cellular counterpart of the viral oncogene mos (c-mos) (Sagata et al., 1989a,b) . Consistent with its proposed role in the regulation of meiosis in oocytes is its time-and site-specific expression. In the mouse, c-mos is expressed only in the developing oocytes and pachytene spermatids (Goldman et al., 1987) . Following fertilization c-mos mRNA disappears rapidly, and cannot be detected beyond the 2-cell stage in the mouse (Goldman et al., 1988) . A negative regulatory sequence in the promoter regions of the c-mos gene is proposed to inhibit Figure 5 . Activation of maturation promoting factor (MPF) is brought about by cdc25 phosphatase, which via dephosphorylation activates the p34 cdc2 kinase. In addition, the cdc25 phosphatase is activated by MPF forming a catalytic loop, capable of rapidly activating the pool of MPF. In oocytes undergoing meiosis, c-mos kinase activates/maintains the activity of MPF, most likely via another kinase, MAP kinase.
c-mos expression in somatic cells (Zinkel et al., 1992) . Also, a putative repressor protein, present in somatic but not in germ cells, capable of binding to the inhibitory sequences in the c-mos promoter has been identified (Xu and Cooper, 1995) . Thus little is known about the regulation of c-mos transcription and the mechanisms behind its germ line-specific expression.
C-mos kinase has been proposed to enhance MPF activity via several mechanisms. Indirect activation of MPF via MAP kinase has been suggested (Nebreda and Hunt, 1993; Roy et al., 1996) . In mouse oocytes, c-mos inhibits proteolytic degradation of cyclin-B, which, in turn leads to the accumulation of cyclin-B between meiosis I and II (O' Keefe et al., 1991) , and maintains high MPF activity during metaphase arrest (Kubiak et al., 1993) .
The presence of c-mos kinase is thus needed for proper progression of meiotic division. Blocking c-mos activity in mouse oocytes either by injection of antibodies to c-mos protein (Zhao et al. 1990 ), or by antisense oligonucleotides, prevents meiosis II (O' Keefe et al., 1989; Paules et al., 1989) . Furuno et al. (1994) have shown that in Xenopus, the net result of c-mos-maintained high MPF activity is inhibition of DNA replication between meiosis I and II (Figure 4) , which normally enables reductive cell division and thus inhibition of parthenogenic activation of the oocyte. Due to its capacity to maintain the oocytes at metaphase II arrest, c-mos has also been referred to as cytostatic factor (CSF). In c-mos knockout mice, metaphase II arrest fails, resulting in a high degree of parthenogenic activation of the oocytes (Colledge et al., 1994; Hashimoto et al., 1994) .
As in the mouse, the expression of c-mos is limited to the oocyte both in cynomolgus monkey and human (Pal et al., 1994; Heikinheimo et al., 1995a,b) . Moreover, in the human pre-embryos, c-mos expression cannot be detected beyond the 6-cell stage (Heikinheimo et al., 1995b) , suggesting a similar meiosis-specific role for c-mos also in human. Parthenogenic activation of the human oocytes can be induced with inhibitors of protein synthesis . It may be 750 speculated that inhibition of protein synthesis inhibits the translation of c-mos protein, likely to be required to maintain human oocytes in meiosis II arrest. Lack of c-mos might thus allow the two stages of meiosis to continue uninterrupted, resulting in parthenogenic activation.
Fertilization triggers Ca 2⍣ oscillations and terminates meiosis
Fertilization triggers a wave of oscillations in the intracellular concentrations of calcium. This has been characterized in human oocytes following fertilization in vitro (Taylor 1994; Tesarik et al., 1995) or intracytoplasmic sperm injection (ICSI) (Tesarik et al., 1994) .
The mechanism(s) of Ca 2ϩ oscillations are a subject of intense research, and have also recently been reviewed this journal (Berridge, 1996; Swann and Lawrence, 1996; Tesarik and Sousa, 1996; Wilding and Dale, 1997) . In brief, two separate mechanisms triggering the Ca 2ϩ release have been proposed. The first involves the binding of the spermatozoon to a hypothetical G protein-coupled receptor on the oocyte surface; this results in the activation of phospholipase-C and the release of inositol 1,4,5-trisphosphate (InsP3) (Wilding and Dale, 1997) . The second possible mechanism involves a soluble 'sperm factor' contained within the spermatozoa and released into the oocyte at fertilization (Wilding and Dale, 1997) . Oscillin, a strong candidate as the 'sperm factor', is a 33 kDa protein present in the fractions of hamster spermatozoa, which are capable of triggering the Ca 2ϩ oscillations in mouse eggs (Parrington et al., 1996) . Human spermatozoa also contain oscillin in the equatorial plane (Parrington et al., 1996) . However, human spermatozoa also contain high concentrations of InsP3, an additional putative 'sperm factor' (Tosti et al., 1993; Berridge, 1996) .
Similarly, two partly overlapping mechanisms controlling the release of Ca 2ϩ from intracellular stores, namely InsP3-and ryanodine-mediated, have been characterized in human oocytes . The InsP3-and ryanodine-dependent Ca 2ϩ release mechanisms appear to have different sensitivity to Ca 2ϩ -induced Ca 2ϩ release, and to be differently distributed within the oocyte. This two-store model has been proposed to explain the Ca 2ϩ oscillation following fertilization -the initial Ca 2ϩ release from stores located at the oocyte periphery is activated following sperm binding, and serves to trigger the Ca 2ϩ oscillations from the central Ca 2ϩ stores (Tesarik et al., 1995) . The spatiotemporal differences in Ca 2ϩ oscillations following fertilization of mouse eggs in vitro, or by ICSI, further support the two-store model (Nakano et al., 1997) . Following IVF, the Ca 2ϩ oscillations commence at the site of sperm attachment, continue in the oocyte periphery and finally in the central regions of the oocyte. However, after ICSI, the Ca 2ϩ oscillations are initiated with a delay, but simultaneously throughout the oolemma (Nakano et al., 1997) . Also in human oocytes, the patterns of Ca 2ϩ oscillations following IVF and ICSI are different (Taylor, 1994; Tesarik et al., 1994) , supporting the two-store model of Ca 2ϩ release in human oocytes as well.
The significance of the pattern of Ca 2ϩ release is beginning to emerge. A recent study by Raz et al. (1998) in rat eggs showed that two aspects of egg activation, cortical reaction and resumption of meiosis, depend on the magnitude Ca 2ϩ release. Lower Ca 2ϩ transients trigger cortical reaction whereas higher Ca 2ϩ rises are needed for the resumption of meiosis (Raz et al., 1998) . The capacity for repeated Ca 2ϩ release in response to thiomercal, a Ca 2ϩ mobilizing agent, appears to develop late in the human eggs. The Ca 2ϩ oscillations characteristic of in-vivo matured oocytes was not seen in the immature or in-vitro matured oocytes (Herbert et al., 1997) : this may partly explain the reduced developmental capacity of the in-vitro matured oocytes (Trounson et al., 1994; Barnes et al., 1996) .
Ca 2⍣ oscillations and degradation of MPF: proposed mechanisms
In Xenopus oocytes, the oscillations in Ca 2ϩ result in the activation of proteolytic enzymes, capable of degrading c-mos and cyclin-B, resulting in the inactivation of MPF, and thus completion of meiosis II (Lorca et al., 1994) . Specifically, in Xenopus eggs, cyclin-B is degraded via calmodulin-dependent protein kinase II (Lorca et al., 1993) , and c-mos via a ubiquination pathway (Ishida et al., 1993) .
Following fertilization in vitro, the oscillations in intracellular Ca 2ϩ commence rapidly, at~20-35 min (Taylor, 1994) , whereas following ICSI, the oscillations are seen at 4-12 h (Tesarik et al., 1994) . The second polar body, marking completion of meiosis II, is being extruded at 3 h following IVF of human oocytes (Lopata et al., 1980) . Thus, the timetable of Ca 2ϩ oscillations, and presumed degradation of active MPF, (allowing for the fertilized oocyte to leave the meiosis) go hand in hand. In addition, the first S-phase, also necessitating inactivation of MPF, starts~9-10 h following fertilization of human oocytes . Fertilization, completion of meiosis II and the proposed molecular mechanisms are summarized in Figure 6 .
Parthenogenic activation of oocytes has therefore been attempted by artificially increasing the intra-oocyte concentra-751 tions of Ca 2ϩ . Oocytes from different species vary in their sensitivity to alterations in Ca 2ϩ , the human eggs apparently being more resistant than those of mice. However, following treatment with Ca 2ϩ ionophores, cleavage rates of 16-60% have been reported for human eggs (Winston et al., 1991; .
Human pre-embryo
From maternal to embryonic control
The time-point of activation of the embryonic genome and the initiation of RNA synthesis and thus eventually transition from maternal to embryonic control varies in different species. In the mouse, the zygotic gene expression occurs at the 2-cell stage, whereas in larger domestic animals such as pig and cow, this happens at 8-and 16-cell stages respectively (Telford et al., 1990) .
Initiation of embryonic gene expression in human preembryos has been assessed by several approaches. Namely human pre-embryos of different developmental stages have been evaluated for their sensitivity to inhibitors of transcription (Braude et al., 1988) , incorporation of radiolabelled nucleotides or amino acids into newly synthesized RNA or protein (Tesarik et al., 1986; Braude et al., 1988) , quantitative analysis of specific mRNA molecules (Heikinheimo et al., 1995b) as well as the appearance of parenterally imprinted mRNA molecules (Lighten et al., 1997) . All these different lines of evidence suggest that in human pre-embryos, the embryonic transcription commences between 4-and 8-cell stages.
The reason(s) for the delay in commencement of the embryonic gene expression are obscure. cAMP-dependent protein kinase-mediated mechanisms have been implicated in the activation of the embryonic genome (Schwartz and Schultz, 1992) . Recent work by Prioleau et al. (1994) suggests that a large abundance of histone proteins in Xenopus oocytes rapidly bind to the newly formed DNA molecules thus making them inaccessible to the transcription machinery. However, at the time of initiation of zygotic gene expression the pool of histones is sufficiently diluted, allowing the commencement of RNA synthesis (Prioleau et al. 1994) .
The initiation of embryonic control coincides with the disappearance of the maternally inherited stores of RNA. Shortening of the poly-A tail initiates the process of mRNA degradation (Decker and Parker, 1994) . However, in mouse embryos, some maternal mRNA species, such as tissue plasminogen activator, are actually polyadenylated and thus translationally activated following fertilization (Paynton and Bachvarova, 1994) . Thus, the rate of degradation of specific mRNA molecules varies following fertilization. In human embryos, the maternally inherited c-mos mRNA cannot be detected beyond the 6-cell stage (Heikinheimo et al., 1995b) . Thus as judged solely by the disappearance of c-mos mRNA, the maternal stores of mRNA are rapidly depleted following fertilization in the human (Figure 7 ).
The early transcripts in human embryos (Figure 8)
Between fertilization and implantation, the human pre-embryo becomes an increasingly complex structure. Yet the cytoplasmic Figure 6 . Fertilization triggers continuation of meiosis II. The ovulated oocyte is maintained at metaphase II nuclear status by increased maturation promoting factor (MPF) activity (A). Fertilization triggers continuation of meiosis II, resulting in a two-pronuclear pre-embryo displaying two polar bodies and pronucleus (B). The proposed molecular mechanisms are shown at the bottom: the fertilizing spermatozoon induces oscillations in the intra-oocyte concentrations of Ca 2ϩ . This results in proteolytic degradation of c-mos and cyclin-B, and thus discontinuation of MPF activity, which allows the pre-embryo to leave meiosis and resume regular cell divisions. mass of the pre-embryo is not increased prior to blastocyst stage (McLaren, 1982) . The advancing development is associated with diminishing totipotency, thus the developmental potential of individual blastomeres separated from an 8-cell stage embryo is clearly reduced in comparison to that of a 2-cell stage human embryo (Hall et al., 1993) .
Recent evidence suggests that the differentation of individual blastomeres may be initiated at these very early steps of embryo development. Immunohistochemical detection of cytokine leptin, and the transcription factor STAT3 revealed polarized distribution already in oocytes (Antczak and Van Blerkom, 1997) . The uneven distribution of leptin and STAT3 persisted throughout pre-embryo development, possibly contributing to subsequent development of inner and outer cell masses (Antczak and Van Blerkom, 1997) . Similarly, considerable variation in the concentrations of β-actin and IL-1RI mRNA between individual blastomeres originating from the same 6-8-cell stage pre-embryo were noted (Krüssel et al., 1998) . Thus individual characteristics, which might represent signs 752 of initial differentiation, are present in blastomeres already at these early stages. These findings might bear clinical significance to preimplantation genetic diagnostics: is the blastomere studied representative of the embryo as a whole, and does the biopsy procedure remove the blastomere crucial for subsequent development?
The first embryonic cell cycles are characteristically rapid; in human embryos the duration of the first cell cycle is~20-22 h . Accordingly, B-type cyclins, also needed for mitotic cell divisions, are among the first genes to be expressed following initiation of the zygotic gene expression. In human pre-embryos an increase in the concentrations of cyclin-B1 mRNA was evident after 6-cell stage (Heikinheimo et al., 1995b) .
As shown by the high percentage of mosaicism in the preimplantation human embryo (Munné et al., 1994) , the cell cycle control mechanisms are not fully developed at this early stage of development. Recent work by Fulka et al. (1997) has shown that damaged chromatin does not prevent cell cycle progression in fused mouse oocytes. In line with this, tumour suppressor p21 mRNA, one of the proteins involved in the control of chromatin integrity, is barely detectable in the oocyte and 4-cell embryo, whereas increased concentrations of p21 mRNA are detectable in the blastocyst stage (Heikinheimo et al., 1996) . p21 protein belongs to an enlarging family of tumour suppressor proteins (Peter and Herskowitz, 1994) and acts via inhibition of the activity of several cyclin-cdk complexes in vitro (Xiong et al., 1993) ; also the expression of p21 is associated with cellular differentiation (Parker et al., 1995) . Thus additional levels of cell cycle regulation emerge as the embryonic development progresses. In addition, apoptotic mechanisms are increasingly modifying the development of the human embryo (Hardy et al., 1989) .
Among the first transcripts expressed by the human preembryo are several potentially growth modulatory proteins, such as IGF-II (Lighten et al., 1997) , several IGF-binding . In human pre-embryos, the embryonic gene expression starts between 4-and 8-cell stages. ACTR ϭ activin receptors; Cx43 ϭ connexin 43 (a gap junction protein); EGF ϭ epidermal growth factor; EGF-R ϭ EGF receptor; ER ϭ oestrogen receptor; IGFBP ϭ insulin-like growth factor binding proteins; IGF-I and -II ϭ insulin-like growth factor-I and -II; IGF-IR ϭ IGF-I receptor; IL-1β ϭ interleukin 1β; LIF-R ϭ leukaemia inhibitory factor receptor; Oct-4 and -6 ϭ octameric transcription factors 4 and 6; p21 ϭ tumour suppressor p21; steel ϭ stem cell factor; the corresponding references are found in the text.
proteins (Liu et al., 1997) , c-kit tyrosine kinase and tumour necrosis factor receptors (Sharkey et al., 1995) , suggesting a capacity to respond to extracellular stimuli. Also, human preembryos contain 'steel' factor (or stem cell factor) mRNA, the ligand for the c-kit receptor, thus making an autocrine regulatory pathway possible (Sharkey et al. 1995) . A recent report indicates that follicular fluid concentrations of stem cell factor were increased in IVF patients achieving successful pregnancy (Smikle et al., 1998) .
Both oocytes and pre-embryos contain mRNA for transcription factor Oct-4 (Abel-Rahman et al., 1995) , which may have a role in regulating the early embryonic transcription. In addition, Oct-6 mRNA is detectable after the 10-cell stage (Abel-Rahman et al., 1995) . Gap-junction protein connexin-43 is expressed from 4-cell stage onward, making cell-cell communication between the individual blastomeres possible (Hardy et al., 1996) .
The molecular mechanisms of implantation are emerging. Of the several candidate molecules, leukaemia inhibitory factor (LIF), secreted by the uterine epithelium, and interleukin-1 (IL-1) are obligatory for implantation in the mouse . Accordingly, in human pre-embyos, LIF-receptor mRNA expression is initiated by the blastocyst stage (Sharkey et al., 1995) . In addition, the components of the IL-1 system, namely IL-1β, IL-1 receptor type I and IL receptor antagonist, are present in human oocytes and pre-embryos (Simon et al., 1995) .
Practical considerations
Increased understanding of the basic biology of the human oocyte and early embryo is likely to enhance the treatment of the infertile patient in several ways. The practical questions concerning the optimal culture systems of human oocytes and 753 embryos can now be assessed. Previously it has been shown that culture conditions affect both MPF activity (Naito et al., 1992) and RNA kinetics (Ho et al., 1994) in experimental IVF. As the use of immature human oocytes is becoming an option in clinical IVF (Cha et al., 1991; Trounson et al., 1994) , understanding of the maturation process and the factors regulating it, is likely to help in the optimization of the invitro maturation conditions. Similarly, defining the growth factors modifying early human embryogenesis will allow perfection of the in-vitro culture of the human pre-embryos.
More distant scenarios involve dissection of cytoplasmic and nuclear maturation, as well as the understanding of their differential regulation. Is the reduced clinical potential of oocytes derived from certain subgroups, such as older women, or women with cytoplasmic or nuclear factors. Moreover, could such defects be pinpointed to a common single 'factor' present in improper amounts? Finally, if certain clinical conditions could be ameliorated by the transplantation of subcellular organelles, such as nuclear transfer, how would the 'transplants' begin to function in their new surroundings? Even more specifically, could certain genetic defects be corrected in the future via germ cell gene therapy?
During the two decades following the birth of the first IVF baby, the understanding of the basic biology of the oocyte and pre-embryo has increased significantly. Yet one is forced to conclude that we are only at the beginning of the path. However, we now have the tools to answer some of the questions. Defining the initiation of embryonic gene expression in human embryos poses us with the question of when does life begin -with the potential of unique genetic combinations at fertilization or at the 4-8-cell stage when this potential is being exploited? Therefore as our knowledge on the molecular mechanisms and regulatory networks of human oocyte and preembryo development increases, we must also be continuously prepared to face, and endeavour to answer, the continually emerging new moral issues of assisted reproductive techniques.
